Dixon Mitchell Investment Counsel Inc. Teva Pharmaceutical Industries LTD Transaction History

Dixon Mitchell Investment Counsel Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2012 Jan 17, 2024	SELL	N/A	-259,430 Closed	0 $0
Q3 2012 Jan 17, 2024	BUY	N/A	23,429 Added 9.93%	259,430 $10.7 Billion
Q2 2012 Jan 17, 2024	BUY	N/A	3,167 Added 1.36%	236,001 $9.31 Billion
Q1 2012 Jan 17, 2024	SELL	N/A	-18,715 Reduced 7.44%	232,834 $10.5 Billion
Q4 2011 Jan 17, 2024	SELL	N/A	-10,696 Reduced 4.08%	251,549 $10.2 Billion
Q3 2011 Jan 17, 2024	SELL	N/A	-3,101 Reduced 1.17%	262,245 $9.76 Billion
Q2 2011 Jan 17, 2024	BUY	N/A	61,886 Added 30.42%	265,346 $12.8 Billion
Q1 2011 Jan 17, 2024	BUY	N/A	203,460	203,460 $10.2 Billion

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.